Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Donghua Yin
Safety, Tolerability, and Pharmacokinetics of the Anti-Igf-1r Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects
British Journal of Clinical Pharmacology
Pharmacology
A Humanised Anti-Igf-1r Monoclonal Antibody (AVE1642) Enhances Bortezomib-Induced Apoptosis in Myeloma Cells Lacking CD45
British Journal of Cancer
Cancer Research
Oncology
SAT0235 BIIB059, a Monoclonal Antibody Targeting BCDA2 Shows Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteer Subjects
Combinational Therapy Enhances the Effects of Anti-Igf-1r mAb Figitumumab to Target Small Cell Lung Cancer
PLoS ONE
Multidisciplinary
Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Initial Testing of a Monoclonal Antibody (IMC-A12) Against IGF-1R by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients With Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake
Clinical Cancer Research
Cancer Research
Oncology
Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
